In gastric cancer, TGFβ2 correlated with poorer prognosis than TGFβ1 [44], and in malignant gliomas and nasopharyngeal carcinoma, TGFβ2 was associated with malignancy [45,46]. This evidence concerns the gene TGFB2 and malignant glioma.